PD1A Stock Chart & Stats
Currently, no data available
Please return soon. This page is being updated.
Bulls Say, Bears Say
Bulls Say
Margin ExpansionMaterial margin expansion shows Ansell can convert revenue into higher operating profits via pricing, procurement and integration benefits. Sustained ~14%+ EBIT margins provide durable earnings cushion to absorb cost shocks and fund reinvestment, supporting long-term cash flow.
Strong Cash ConversionCash conversion above 100% indicates recurring profitability efficiently turning into cash, enabling capital allocation flexibility. High conversion supports funding for manufacturing expansion, buybacks and debt management without relying on external financing over the medium term.
Healthy Balance SheetModerate leverage and a strong equity base give Ansell financial flexibility for M&A, capex and shareholder returns. Net debt around 1.5x EBITDA leaves headroom for cyclical stress and supports continued investment in capacity and product development.
Bears Say
Tariff ExposureAn $80M annualized tariff is a structural cost headwind that can persist absent durable policy relief. Passing costs via pricing may reduce demand in price-sensitive markets and compress volume in export-dependent regions, limiting sustainable margin gains.
Commodity Volume DeclinesDeclining volumes in commodity exam gloves pressures revenue and overall margin mix over time. If volume trends persist, Ansell must rely increasingly on premium, differentiated products and pricing to sustain growth, which may take time and investment to scale.
Free Cash Flow WeaknessA notable drop in free cash flow growth reduces the company’s buffer for buybacks, debt paydown and discretionary capex. Even with strong operating cash conversion ratios, weaker FCF growth signals potential working capital or one-off pressures that could constrain strategic flexibility.
Ansell News
PD1A FAQ
What was Ansell’s price range in the past 12 months?
Currently, no data Available
What is Ansell’s market cap?
Ansell’s market cap is CHF2.53B.
When is Ansell’s upcoming earnings report date?
Ansell’s upcoming earnings report date is Aug 24, 2026 which is in 28 days.
How were Ansell’s earnings last quarter?
Ansell released its earnings results on Feb 15, 2026. The company reported CHF0.54 earnings per share for the quarter, beating the consensus estimate of CHF0.52 by CHF0.02.
Is Ansell overvalued?
According to Wall Street analysts Ansell’s price is currently Undervalued.
Does Ansell pay dividends?
Ansell does not currently pay dividends.
What is Ansell’s EPS estimate?
Ansell’s EPS estimate is 0.62.
How many shares outstanding does Ansell have?
Ansell has 140,313,830 shares outstanding.
What happened to Ansell’s price movement after its last earnings report?
Ansell reported an EPS of CHF0.54 in its last earnings report, beating expectations of CHF0.52. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of Ansell?
Currently, no hedge funds are holding shares in CH:PD1A
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Ansell Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
16.18%
12-Months-Change
Fundamentals
Return on Equity
4.43%
Trailing 12-Months
Asset Growth
1.60%
Trailing 12-Months
Company Description
Ansell
Ansell Limited is a global enterprise that conceptualizes, innovates, and produces protective equipment for various industries across numerous regions, including Asia Pacific, Europe, the Middle East, Africa, the Americas, and the Caribbean. The company's operations are divided into two principal divisions: Healthcare and Industrial. The Healthcare division focuses on crafting and distributing products such as surgical, single-use, and examination gloves, alongside specialized cleanroom and sterile gloves and apparel. These offerings cater to a diverse clientele including medical facilities, surgical clinics, dental offices, veterinary practices, emergency services, research laboratories, and pharmaceutical and life science firms. Conversely, the Industrial segment provides hand and chemical protective gear designed for a wide array of demanding applications, from the automotive, chemical, and metal fabrication sectors to machinery, food processing, construction, mining, oil and gas industries, and first responders. Established in 1893 and headquartered in Richmond, Australia, the company was initially known as Pacific Dunlop Limited before rebranding to Ansell Limited in 2002. P. D. Holdings Pty. Ltd. currently operates as a subsidiary of Ansell Limited.
PD1A Stock 12 Month Forecast
Average Price Target
CHF18.97
Nanosonics Limited
―
Medical Developments International Limited
―
Trajan Group Holdings Ltd
―
CleanSpace Holdings Ltd.
―
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh
―